Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Innoviva (INVA) over the last 9 years, with Q1 2024 value amounting to $393.8 million.

  • Innoviva's Treasury Shares changed 0.0% to $393.8 million in Q1 2024 from the same period last year, while for Mar 2024 it was $393.8 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $393.8 million for FY2023, which is 0.0% changed from last year.
  • Latest data reveals that Innoviva reported Treasury Shares of $32.0 million as of Q1 2024, which was down 0.0% from $32.0 million recorded in Q4 2023.
  • Innoviva's Treasury Shares' 5-year high stood at $32.0 million during Q3 2021, with a 5-year trough of -$32.0 million in Q2 2021.
  • Its 4-year average for Treasury Shares is $13.5 million, with a median of $32.0 million in 2021.
  • The largest annual percentage gain for Innoviva's Treasury Shares in the last 5 years was 0.0% (2022), contrasted with its biggest fall of 0.0% (2022).
  • Quarter analysis of 4 years shows Innoviva's Treasury Shares stood at $393.8 million in 2021, then changed by 0.0% to $393.8 million in 2022, then changed by 0.0% to $393.8 million in 2023, then changed by 0.0% to $393.8 million in 2024.
  • Its Treasury Shares stands at $393.8 million for Q1 2024, versus $393.8 million for Q4 2023 and $393.8 million for Q3 2023.